Wells Fargo Maintains Overweight on Johnson & Johnson, Raises Price Target to $287
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice TargetHot
Wells Fargo analyst Larry Biegelsen maintains Johnson & Johnson (NYSE:JNJ) with a Overweight and raises the price target from $275 to $287.
Wells Fargo analyst Larry Biegelsen maintains Johnson & Johnson (NYSE:JNJ) with a Overweight and raises the price target from $275 to $287.